Merck Sharp & Dohme appeals judgment tossing Januvia patent extension

Appeals 2021-09-10 6:04 pm By Miklos Bolza | Sydney

Please login to bookmark

Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au